Cargando…

A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes

Chronic inflammation is postulated to be involved in development of end stage renal disease (ESRD) in diabetes, but which specific circulating inflammatory proteins contribute to this risk remains unknown. To study this we examined 194 circulating inflammatory proteins in subjects from three indepen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niewczas, Monika A., Pavkov, Meda E., Skupien, Jan, Smiles, Adam, Dom, Zaipul I. Md., Wilson, Jonathan M., Park, Jihwan, Nair, Viji, Schlafly, Andrew, Saulnier, Pierre-Jean, Satake, Eiichiro, Simeone, Christopher A., Shah, Hetal, Qiu, Chengxiang, Looker, Helen C, Fiorina, Paolo, Ware, Carl F., Sun, Jennifer K., Doria, Alessandro, Kretzler, Matthias, Susztak, Katalin, Duffin, Kevin L., Nelson, Robert G., Krolewski, Andrzej S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508971/ https://www.ncbi.nlm.nih.gov/pubmed/31011203 http://dx.doi.org/10.1038/s41591-019-0415-5

Ejemplares similares

Effect of TNFα stimulation on expression of kidney risk inflammatory proteins in human umbilical vein endothelial cells cultured in hyperglycemia
por: Md Dom, Zaipul I., et al.
Publicado: (2021)

Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43:2760–2767
por: Ihara, Katsuhito, et al.
Publicado: (2021)

Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014)

Circulating short and medium chain fatty acids are associated with normoalbuminuria in type 1 diabetes of long duration
por: Moon, Salina, et al.
Publicado: (2021)

Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes
por: PAVKOV, MEDA E., et al.
Publicado: (2014)

The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)

Increased plasma Kidney Injury Molecule-1 suggests early progressive renal decline in non-proteinuric patients with Type 1 diabetes
por: Nowak, Natalia, et al.
Publicado: (2016)

Circulating TGF-β1–Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes
por: Pezzolesi, Marcus G., et al.
Publicado: (2015)

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1
por: Lee, Jung Eun, et al.
Publicado: (2013)

Hyperglycemia Regulated Circulating MicroRNAs and Their Effects on Renal Function Decline in Type 2 Diabetes
por: Kobayashi, Hiroki, et al.
Publicado: (2021)

Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes
por: Pavkov, Meda E., et al.
Publicado: (2016)

Transcriptome Analysis of Proximal Tubular Cells (HK-2) Exposed to Urines of Type 1 Diabetes Patients at Risk of Early Progressive Renal Function Decline
por: Wanic, Krzysztof, et al.
Publicado: (2013)

Family-Based Association Analysis Confirms the Role of the Chromosome 9q21.32 Locus in the Susceptibility of Diabetic Nephropathy
por: Pezzolesi, Marcus G., et al.
Publicado: (2013)

Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
por: Skupien, Jan, et al.
Publicado: (2014)

Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390
por: Niewczas, Monika A., et al.
Publicado: (2017)

Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017)

Human Kidney Tubule-Specific Gene Expression Based Dissection of Chronic Kidney Disease Traits
por: Beckerman, Pazit, et al.
Publicado: (2017)

Bulk tissue cell type deconvolution with multi-subject single-cell expression reference
por: Wang, Xuran, et al.
Publicado: (2019)

Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming
por: Huang, Shizheng, et al.
Publicado: (2018)

Uremic solutes and risk of end stage renal disease in type 2 diabetes
por: Niewczas, Monika A, et al.
Publicado: (2014)

Serum Concentration of Cystatin C and Risk of End-Stage Renal Disease in Diabetes
por: Krolewski, Andrzej S., et al.
Publicado: (2012)

Exclusion of Polymorphisms in Carnosinase Genes (CNDP1 and CNDP2) as a Cause of Diabetic Nephropathy in Type 1 Diabetes: Results of Large Case-Control and Follow-Up Studies
por: Wanic, Krzysztof, et al.
Publicado: (2008)

Estimating GFR in the Elderly—New Approaches to an Old Problem
por: Pavkov, Meda E., et al.
Publicado: (2019)

Allele-specific RNA imaging shows that allelic imbalances can arise in tissues through transcriptional bursting
por: Symmons, Orsolya, et al.
Publicado: (2019)

Genome-wide association studies identify the role of caspase-9 in kidney disease
por: Doke, Tomohito, et al.
Publicado: (2021)

Integrating Automated Workflows, Human Intelligence and Collaboration
por: Mirel, Barbara, et al.
Publicado: (2009)

Reported Cases of End-Stage Kidney Disease — United States, 2000–2019
por: Burrows, Nilka Ríos, et al.
Publicado: (2022)

From Single Nucleotide Polymorphism to Transcriptional Mechanism: A Model for FRMD3 in Diabetic Nephropathy
por: Martini, Sebastian, et al.
Publicado: (2013)

For Better or Worse: A Niche for Notch in Parietal Epithelial Cell Activation
por: Sweetwyne, Mariya, et al.
Publicado: (2013)

Trends in Hospitalizations for Acute Kidney Injury — United States, 2000–2014
por: Pavkov, Meda E., et al.
Publicado: (2018)

Getting a Notch Closer to Understanding Diabetic Kidney Disease
por: Ahn, Seon-Ho, et al.
Publicado: (2010)

Fat Burning Problem in Cystic Kidneys: an Emerging Common Mechanism of Chronic Kidney Disease
por: Li, Szu Yuan, et al.
Publicado: (2016)

Increased levels of endogenous retroviruses trigger fibroinflammation and play a role in kidney disease development
por: Dhillon, Poonam, et al.
Publicado: (2023)

Does NIH funding differ between medical specialties? A longitudinal analysis of NIH grant data by specialty and type of grant, 2011–2020
por: Schlafly, Andrew, et al.
Publicado: (2022)

Kick it up a notch: Notch signaling and kidney fibrosis
por: Sweetwyne, Mariya T, et al.
Publicado: (2014)

Genetic Variant at the GLUL Locus Predicts All-Cause Mortality in Patients With Type 2 Diabetes
por: Prudente, Sabrina, et al.
Publicado: (2015)

Renal compartment-specific genetic variation analyses identify new pathways in chronic kidney disease
por: Qiu, Chengxiang, et al.
Publicado: (2018)

Kidney cytosine methylation changes improve renal function decline estimation in patients with diabetic kidney disease
por: Gluck, Caroline, et al.
Publicado: (2019)

Estimation of chronic kidney disease incidence from prevalence and mortality data in American Indians with type 2 diabetes
por: Vijayakumar, Pavithra, et al.
Publicado: (2017)

Combing Genome-Wide Association Studies and Single-Cell Analysis to Elucidate the Mechanisms of Kidney Disease: Proceedings of the Henry Shavelle Professorship
por: Levinsohn, Jonathan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q4c7ogmjk04jg58g3k6fvh6t62